Hoth Therapeutics Inc (HOTH)

Currency in USD
1.0200
+0.0400(+4.08%)
Closed·
1.0000-0.0200(-1.96%)
·
HOTH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.96021.0600
52 wk Range
0.65542.1150
Key Statistics
Prev. Close
0.98
Open
1
Day's Range
0.9602-1.06
52 wk Range
0.6554-2.115
Volume
713.9K
Average Volume (3m)
441.42K
1-Year Change
-9.7345%
Book Value / Share
0.62
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HOTH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
5.0000
Upside
+390.20%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Hoth Therapeutics Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Hoth Therapeutics Inc Company Profile

Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It develops HT-001, a topical formulation in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer’s or other neuroinflammatory diseases; and HT-004 for treatment of asthma and allergies using inhalational administration. The company is developing BioLexa Platform, a proprietary, patented, drug compound platform in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc.; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.; and Voltron Therapeutics, Inc. The company was incorporated in 2017 and is headquartered in New York, New York.

Employees
3

Compare HOTH to Peers and Sector

Metrics to compare
HOTH
Peers
Sector
Relationship
P/E Ratio
−1.3x−1.4x−0.5x
PEG Ratio
−0.05−0.010.00
Price/Book
1.9x0.9x2.6x
Price / LTM Sales
-5.8x3.3x
Upside (Analyst Target)
390.2%295.4%47.1%
Fair Value Upside
Unlock13.8%5.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 5.0000
(+390.20% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 12, 2025
EPS / Forecast
-0.30 / -0.27
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

HOTH Income Statement

People Also Watch

2.1700
SIDU
+5.85%
8.020
RDW
+1.65%
22.420
PL
+5.26%
9.310
ONDS
+3.79%
6.140
GSIT
+4.07%

FAQ

What Is the Hoth Therapeutics (HOTH) Stock Price Today?

The Hoth Therapeutics stock price today is 1.0200.

What Stock Exchange Does Hoth Therapeutics Trade On?

Hoth Therapeutics is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Hoth Therapeutics?

The stock symbol for Hoth Therapeutics is "HOTH."

What Is the Hoth Therapeutics (HOTH) Afterhours Price Today? (Afterhours variable test: 1.0000) Current Date: 15 Feb 2026

After hours price: 1.0000. After hours price change (units): -0.0200. Price change percentage: -1.9600%

What Is the Hoth Therapeutics Market Cap?

As of today, Hoth Therapeutics market cap is 15.8200M.

What Is Hoth Therapeutics's Earnings Per Share (TTM)?

The Hoth Therapeutics EPS (TTM) is -1.01.

From a Technical Analysis Perspective, Is HOTH a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Hoth Therapeutics Stock Split?

Hoth Therapeutics has split 1 times.

How Many Employees Does Hoth Therapeutics Have?

Hoth Therapeutics has 3 employees.

What is the current trading status of Hoth Therapeutics (HOTH)?

As of 15 Feb 2026, Hoth Therapeutics (HOTH) is trading at a price of 1.0200, with a previous close of 0.9800. The stock has fluctuated within a day range of 0.9602 to 1.0600, while its 52-week range spans from 0.6554 to 2.1150.

What Is Hoth Therapeutics (HOTH) Price Target According to Analysts?

The average 12-month price target for Hoth Therapeutics is USD5.0000, with a high estimate of USD5 and a low estimate of USD5. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +390.20% Upside potential.

What Is the HOTH Premarket Price?

HOTH's last pre-market stock price is 1.0099. The pre-market share volume is 4,900.0000, and the stock has decreased by 0.0299, or 3.0500%.

What Is the HOTH After Hours Price?

HOTH's last after hours stock price is 1.0000, the stock has decreased by -0.0200, or -1.9600%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.